Open AccessTeneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario
Author(s) -
Kiran Shah
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/27013.10003
Subject(s) - medicine , renal function , gastroenterology , postprandial , type 2 diabetes mellitus , diabetes mellitus , creatinine , type 2 diabetes , kidney disease , statistical significance , diabetic retinopathy , dipeptidyl peptidase 4 inhibitor , lipid profile , urology , endocrinology
Teneligliptin is a recently developed Dipeptidyl Peptidase 4 (DPP4) inhibitor. Teneligliptin is suitable for glycaemic control with renal impairment including end stage renal disease.